AstraZeneca has launched an online direct-to-consumer (DTC) medicine platform in the US, joining a growing list of companies ...
Our annual healthcare roundtable sizes up the risks and opportunities as public policy shifts. 16 stocks to buy now.
Ozempic, marketed by Novo Nordisk in India, is primarily indicated for the treatment of type 2 diabetes. While it can lead to ...
The intertwined rise of obesity and type 2 diabetes, termed 'diabesity,' presents a significant health challenge in India. This condition, driven by complex factors beyond lifestyle, faces stigma ...
DelveInsight's SGLT2 Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...
Are GLP-1 weight loss drugs the best we can do? Learn why some are pursuing alternatives to appetite suppression.
Lower eGFRs were associated with higher likelihood of developing kidney failure and death among adults with diabetes, ...
Pfizer enters the obesity drug market with its Metsera acquisition, aiming to challenge leaders Eli Lilly and Novo Nordisk.
Pfizer Inc. acquires Metsera, Inc. to re-enter the obesity drug market. Click for my look at PFZ and MTSR stock and where I ...
Bagsværd, Denmark Saturday, September 20, 2025, 11:00 Hrs [IST] ...
FOR many, fat jabs have done a world of good – dulling hunger pangs and banishing maddening “food noise”, causing pounds to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback